Healthy Longevity ScienceExplore the questions behind healthy longevity. Understand the evidence, its possibilities and its limits.
4 articles
Measuring healthCHIP and CCUS describe blood-cell changes that can help specialists assess blood-cancer risk and follow-up needs; a mutation alone is not a cancer diagnosis. AgeCurve’s Cell Tree Rings studies a separate use of blood-cell relationships: estimating age. Healthy Longevity Clinic explains what each result means, how cardiovascular risk fits in, and its own contribution to the Cell Tree Rings research.
Measuring healthOccuity PM1 measures corneal thickness; its Indigo and SD1 programs explore glucose measurement and diabetes-risk screening. These uses differ from LumineticsCore, which has a defined US authorization for diabetic retinopathy screening. Healthy Longevity Clinic compares the evidence for each approach and explains when an eye measurement could guide follow-up, protect vision or support a more informed health decision.
Measuring healthSiPhox Health illustrates the growing interest in home blood testing. Studies of selected capillary tests show useful agreement with venous results, including after mailing, but sample quality and the exact assay matter. Healthy Longevity Clinic explains the difference between home collection and home analysis, which results can guide care, and when repeating a test is likely to add useful information.
Measuring healthGalleri received a favorable FDA advisory-panel vote on September 23, 2026. That is a meaningful step toward approval. For someone considering the blood test, the next question is what it adds to existing cancer screening. NHS-Galleri found encouraging detection signals but did not meet its primary combined stage III–IV endpoint; a reduction in cancer deaths remains unproven.